SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    T-F Wang, M A Fiala, A F Cashen, G L Uy, C N Abboud, T Fletcher, N Wu, P Westervelt, J F DiPersio, K E Stockerl-Goldstein, R Vij, A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma, Bone Marrow Transplantation, 2014,

    CrossRef

  2. 2
    Adam Walter-Croneck, Norbert Grzasko, Maria Soroka-Wojtaszko, Artur Jurczyszyn, Tigran Torosian, Marcin Rymko, Adam Nowicki, Agnieszka Druzd-Sitek, Ewa Lech-Maranda, Elzbieta Madro, Patrycja Zielinska, Iwona Grygoruk-Wisniowska, Danuta Blonska, Lidia Usnarska-Zubkiewicz, Stanislaw Potoczek, Elzbieta Iskierka, Anna Masternak, Jadwiga Holojda, Dorota Dawidowska, Ludmila Gawron, Agnieszka Barchnicka, Magdalena Olszewska-Szopa, Malwina Rybicka, Agnieszka Gontarska, Anna Jachalska, Piotr Rzepecki, Edyta Subocz, Piotr Boguradzki, Grzegorz Charlinski, Monika Dzierzak-Mietla, Katarzyna Wisniewska-Piaty, Wojciech Swistek, Agnieszka Kopacz, Beata Blajer-Olszewska, Alina Swiderska, Anna Dmoszynska, Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective—A report by Polish Myeloma Study Group, Leukemia Research, 2014, 38, 7, 788

    CrossRef

  3. 3
    Kai Hübel, Javier Rubia, Nabih Azar, Paolo Corradini, Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective, European Journal of Haematology, 2014, 93, 3
  4. 4
    Gordon Cook, Cathy Williams, Julia M Brown, David A Cairns, Jamie Cavenagh, John A Snowden, A John Ashcroft, Marie Fletcher, Chris Parrish, Kwee Yong, Jim Cavet, Hanna Hunter, Jenny M Bird, Anna Chalmers, Sheila O'Connor, Mark T Drayson, Treen C M Morris, High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial, The Lancet Oncology, 2014, 15, 8, 874

    CrossRef

  5. 5
    Rong Li, Jianfei Qian, Wenhao Zhang, Weijun Fu, Juan Du, Hua Jiang, Hui Zhang, Chunyang Zhang, Hao Xi, Qing Yi, Jian Hou, Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma, British Journal of Haematology, 2014, 166, 5
  6. 6
    H. Goldschmidt, M.-S. Raab, K. Neben, K. Weisel, I.G.H. Schmidt-Wolf, Strategien beim rezidivierten/refraktären multiplen Myelom, Der Onkologe, 2014, 20, 3, 250

    CrossRef